New Medtronic Drug-Eluting Stent FDA approved specifically for diabetes patients
I am a professor for a radiologic technology program and so I enjoy seeing things that mesh the field of radiology (specifically vascular/interventional stuff since I worked as a cardiovascular RT when I was working in the clinical setting) and diabetes.
Earlier this year, Medtronic received FDA approval for a new DES (drug eluting stent) that is specifically marketed with a first-of-its-kind clinical indication for patients with CAD (coronary artery disease) and diabetes.
It is interesting/noteworthy because the 2 year target lesion failure rate is relatively low (par with other DES, but specifically an improvement in individuals who also have diabetes compared to some others on the market right now). A study is still ongoing to track patient outcomes for future success.
You can read more of the story here...
Advertisement
REsources
Groups
From the Diabetes Hands Foundation blog...
How do you measure the work of volunteers?
329,040 minutes, 329,040 moments so dear. 329,040 minutes — How do you measure, measure volunteers? In smileys, in tears shed, in counsel, in cups of coffee. In units, in carb counts, in laughter, in strife. In 329,040 minutes – how …Continue Reading
DHF Expands Board of Advisors
Diabetes Hands Foundation has always relied on partners and advisors to increase its understanding of the diabetes space, in order to better serve people touched by diabetes. Today this is as true as ever, as we proudly announce the expansion …Continue Reading
TuDiabetes Team
DHF STAFF
 Manny Hernandez(Co-Founder, Editor, has LADA)
|
DHF VOLUNTEERS
Lead Administrator
 Bradford (has type 1) |
Administrators
 Lorraine (mother of type 1) |
 Marie B (has type 1) |
|
|
|
|
|
|
LIKE us on Facebook
Spread the word
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2013 A community of people touched by diabetes, run by the Diabetes Hands Foundation.
